drugset / Trial / NCT03145259
Evaluation of Bioavailability of Diclofenac Dermal Products
Phase 0
Completed
12 enrolled
University of Maryland, Baltimore
Food and Drug Administration (FDA) · collab
Non-randomizedCrossoverOpen-labelOther
Summary
The study will utilize already FDA-approved marketed diclofenac products in healthy adults to generate data for establishing rate of drug delivery comparisons between diclofenac epolamine patches and diclofenac sodium solution in healthy adults and to determine skin concentrations.
Timeline
- Start
- 2017-04-19
- Primary completion
- 2019-08-29
- Completion
- 2020-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diclofenac | Other / unclassified | — | Topical |
Indications
No indication recorded.